Nu Skin Enterprises (NYSE: NUS) reported Q3 EPS of $0.76, in-line with the analyst estimate of $0.76. Revenue for the quarter came in at $563.7 million versus the consensus estimate of $562.07 million.

GUIDANCE:

Nu Skin Enterprises sees Q4 2017 EPS of $1.16-$1.21, versus the consensus of $1.19. Nu Skin Enterprises sees Q4 2017 revenue of $650-670 million, versus the consensus of $664.9 million.

For earnings history and earnings-related data on Nu Skin Enterprises (NUS) click here.